Preparation and quality control of 211At‐labelled and 125I‐labelled monoclonal antibodies. Biodistribution in mice carrying human osteosarcoma xenografts
- 1 August 1994
- journal article
- Published by Wiley in Journal of Labelled Compounds and Radiopharmaceuticals
- Vol. 34 (8) , 773-785
- https://doi.org/10.1002/jlcr.2580340811
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- 211At‐labelling of polymer particles for radiotherapy: Synthesis, purification and stabilityJournal of Labelled Compounds and Radiopharmaceuticals, 1993
- B-Cell Hybridoma as Intraperitoneal Tumor Model: Correlation Between Tumor Growth and Monoclonal Antibody ProductionHybridoma, 1992
- Astatine-211 labeling of an antimelanoma antibody and its Fab fragment using N-succinimidyl p-[211At]astatobenzoate: comparisons in vivo with the p-[125I]iodobenzoyl conjugateBioconjugate Chemistry, 1991
- Synthesis of radioiodinated N-succinimidyl iodobenzoate: Optimization for use in antibody labellingInternational Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, 1989
- A microdosimetric model of astatine-211 labeled antibodies for radioimmunotherapyInternational Journal of Radiation Oncology*Biology*Physics, 1987
- Limitations to the killing of tumours using radiolabelled antibodiesThe British Journal of Radiology, 1987
- New monoclonal antibodies specific for human sarcomasInternational Journal of Cancer, 1986
- Determination of the immunoreactive function of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excessJournal of Immunological Methods, 1984
- The nature of the astatine-protein bondThe International Journal of Applied Radiation and Isotopes, 1981
- Continuous cultures of fused cells secreting antibody of predefined specificityNature, 1975